Article
Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group.
Thrombosis and haemostasis - 1 May 1995
White G C, Shapiro A D, Kurczynski E M, Kim H C, Bergman G E
Abstract excerpt
Monoclonal antibody purified factor IX concentrate, Mononine (Armour Pharmaceutical Company, Kankakee, Illinois, USA), is a recently developed replacement factor concentrate for the treatment of patients with hemophilia B. The pharmacokinetic properties of monoclonal antibody purified factor IX concentrate (MAb Factor IX concentrate) have been evaluated in only small samples of patients, and little is known about...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.